Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion

The aim was to determine whether losartan reduces cigarette smoke (CS)-induced airway inflammation and mucus hypersecretion in an in vitro model and a small clinical trial. Primary human bronchial epithelial cells (HBECs) were differentiated at the air–liquid interface (ALI) and exposed to CS. Expre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:ERJ Open Res
Autores principales: Kim, Michael D., Baumlin, Nathalie, Dennis, John S., Yoshida, Makoto, Kis, Adrian, Aguiar, Carolina, Schmid, Andreas, Mendes, Eliana, Salathe, Matthias
Formato: Artigo
Lenguaje:Inglês
Publicado: European Respiratory Society 2021
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7836504/
https://ncbi.nlm.nih.gov/pubmed/33532463
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00394-2020
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares